- Home
- VRAX vs NVFY Comparison
VRAX vs NVFY Comparison
Compare VRAX & NVFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- NVFY
- Stock Information
- Founded
- VRAX 2013
- NVFY 2003
- Country
- VRAX United Kingdom
- NVFY United States
- Employees
- VRAX N/A
- NVFY N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NVFY Home Furnishings
- Sector
- VRAX Health Care
- NVFY Consumer Discretionary
- Exchange
- VRAX Nasdaq
- NVFY Nasdaq
- Market Cap
- VRAX 5.9M
- NVFY 5.0M
- IPO Year
- VRAX 2022
- NVFY N/A
- Fundamental
- Price
- VRAX $1.08
- NVFY $1.10
- Analyst Decision
- VRAX Strong Buy
- NVFY
- Analyst Count
- VRAX 1
- NVFY 0
- Target Price
- VRAX $3.00
- NVFY N/A
- AVG Volume (30 Days)
- VRAX 72.4K
- NVFY 55.7K
- Earning Date
- VRAX 02-05-2025
- NVFY 05-15-2025
- Dividend Yield
- VRAX N/A
- NVFY N/A
- EPS Growth
- VRAX N/A
- NVFY N/A
- EPS
- VRAX N/A
- NVFY N/A
- Revenue
- VRAX $84,872.00
- NVFY $9,686,975.00
- Revenue This Year
- VRAX $5,169.18
- NVFY N/A
- Revenue Next Year
- VRAX $66.97
- NVFY N/A
- P/E Ratio
- VRAX N/A
- NVFY N/A
- Revenue Growth
- VRAX 7.03
- NVFY N/A
- 52 Week Low
- VRAX $0.65
- NVFY $0.39
- 52 Week High
- VRAX $9.00
- NVFY $2.83
- Technical
- Relative Strength Index (RSI)
- VRAX 51.25
- NVFY 66.80
- Support Level
- VRAX $1.03
- NVFY $0.93
- Resistance Level
- VRAX $1.20
- NVFY $1.19
- Average True Range (ATR)
- VRAX 0.07
- NVFY 0.09
- MACD
- VRAX 0.02
- NVFY -0.00
- Stochastic Oscillator
- VRAX 47.83
- NVFY 65.38
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.